Last Updated: 31-07-2025 | Format: PDF | Report ID:20501 | Author: Clara
| Metrics | Details |
|---|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 1430 |
| Regions | US, Canada, Mexico |
| Segments | By Type (Colorimetric Assays, Fluorescent Assays, Label-Free Assays, ELISA-Based Assays, Dye-Binding Assays, Immunoassays), By Application (Drug Discovery & Development, Disease Diagnosis, Academic Research, Proteomics, Clinical Diagnostics, Others), By Distribution Channels (Direct Sales, Distributors, E-commerce, Retail Pharmacies, Wholesalers, Others), By Technology (Spectrophotometry, Colorimetry, Fluorometry, Mass Spectrometry, Chromatography, Others), By Organization Size (Small, Medium, Large) |
| Players | Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, PerkinElmer, GE Healthcare, Abcam PLC, Danaher Corporation, Promega Corporation, Lonza Group, QIAGEN N.V., VWR International, G-Biosciences, Cell Signaling Technology, Enzo Life Sciences, QuidelOrtho |
Clara
Senior Market Research Analyst
Clara is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Clara brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Clara has helped organizations translate data into actionable growth strategies.
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
North America Newborn Screening Market: by Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types), Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels), Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Hemato Oncology Testing Market: by Type (Assays and Kits, Services), Application (Leukemia, Lymphoma, Myeloma, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Others), Technology (PCR, NGS, IHC, FISH, Cytogenetics, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Protein Crystallization & Crystallography Market: by Type (Reagents, Instruments, Automation & Robotics, Software & Services), Application (Drug Discovery, Structural Biology, Disease Diagnostics, Industrial Applications), Distribution Channels (Online, Offline), Technology (X-ray Crystallography, NMR Spectroscopy, Cryo-Electron Microscopy, Microfluidics), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Transfection Reagents and Equipment Market: by Type (Reagents, Instruments), Application (Biomedical Research, Therapeutic Delivery, Protein Production, Cancer Research, Gene Therapy, Others), Distribution Channels (Direct Tenders, Retail Sales, E-commerce, Distributors, Wholesalers, Others), Technology (Physical, Chemical, Biological, Viral-mediated, Electroporation, Lipofection), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America mRNA Synthesis & Manufacturing Market: by Type (Synthetic mRNA, Modified mRNA, Unmodified mRNA, Self-amplifying mRNA, Circular mRNA, Purified mRNA), Application (Vaccines, Cancer Immunotherapy, Protein Replacement Therapy, Gene Editing, Research Applications, Rare Diseases), Distribution Channels (Direct Sales, Distributors, Online Platforms, Retail Pharmacies, Hospital Pharmacies, Others), Technology (In vitro Transcription, Enzymatic Synthesis, Lipid Nanoparticle Formulation, Purification Technologies, Polymerase Chain Reaction, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025